Results 231 to 240 of about 167,619 (306)

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors [PDF]

, 1999
Tiina Jahkola, Timo Toivonen, Karl von Smitten, Ismo Virtanen, V-M Wasenius, Carl Blomqvist   +5 more
openalex   +1 more source

Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain. [PDF]

J Cereb Blood Flow Metab, 2021
Diaz A, Merino P, McCann P, Yepes MA, Quiceno LG, Torre E, Tomkins A, Zhang X, Hales CM, Tong FC, Yepes M.   +10 more
europepmc   +1 more source

Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury. [PDF]

Ren Fail
Zhang W, Gu Y, Zhou J, Wang J, Zhao X, Deng X, Li H, Yan L, Jiao X, Shao F.   +9 more
europepmc   +1 more source

Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis

, 1996
Fabio Farinati, László Herszényi, M. PIebani, Paolo Carraro, Massimo De Paoli, Romilda Cardin, Giovanni Roveroni, Massimo Rugge, Donato Nitti, Francesco Grigioni, Antonietta D’Errico, R. Naccarato   +11 more
openalex   +1 more source

The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c‐met), autocrine motility factor receptor, and urokinase‐type plasminogen activator receptor [PDF]

, 1998
Keizo Taniguchi, Y Yonemura, N Nojima, Yasuo Hirono, Sachio Fushida, Takashi Fujimura, Koichi Miwa, Yoshio Endo, Hiroshi Yamamoto, Hideomi Watanabe   +9 more
openalex   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients. [PDF]

Int J Mol Sci
Gavriilaki E, Demosthenous C, Evangelidis P, Bousiou Z, Batsis I, Vardi A, Mallouri D, Koravou EE, Spyridis N, Panteliadou A, Karavalakis G, Masmanidou M, Touloumenidou T, Papalexandri A, Poziopoulos C, Yannaki E, Sakellari I, Politou M, Papassotiriou I.   +18 more
europepmc   +1 more source

In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1. [PDF]

Molecules, 2021
Gao C, Shen Q, Tang P, Cao Y, Lin H, Li B, Sun P, Bao B, Wu W.   +8 more
europepmc   +1 more source

The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

Int J Gen Med, 2021
Qin Y, Qiao Y, Wang D, Yan G, Tang C, Ma G.   +5 more
europepmc   +1 more source

Downstream targets of urokinase‐type plasminogen‐activator‐mediated signal transduction [PDF]

, 1998
Marina Konakova, Ferdinand Hucho, Wolf‐Dieter Schleuning   +2 more
openalex   +1 more source

The Diagnostic Accuracy of Procalcitonin, Soluble Urokinase-Type Plasminogen Activator Receptors, and C-Reactive Protein in Diagnosing Urinary Tract Infections in the Emergency Department-A Diagnostic Accuracy Study. [PDF]

J Clin Med
Hertz MA, Johansen IS, Rosenvinge FS, Brasen CL, Andersen ES, Heltborg A, Skovsted TA, Petersen ERB, Cartuliares MB, Nielsen SL, Mogensen CB, Skjøt-Arkil H.   +11 more
europepmc   +1 more source